Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psychological impact of referral to an oncology hospital on patients with an ovarian mass.
Lof P, Engelhardt EG, van Gent MDJM, Mom CH, Rosier-van Dunné FMF, van Baal WM, Verhoeve HR, Hermsen BBJ, Verbruggen MB, Hemelaar M, van de Swaluw JMG, Knipscheer HC, Huirne JAF, Westenberg SM, van Driel WJ, Bleiker EMA, Amant F, Lok CAR. Lof P, et al. Among authors: van gent mdjm. Int J Gynecol Cancer. 2022 Dec 13:ijgc-2022-003753. doi: 10.1136/ijgc-2022-003753. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 36600495
Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research.
Zelisse HS, van Gent MDJM, de Ridder S, van der Aa MA, van Altena AM, Bart J, Belien JAM, Boere IA, Bosch SL, Broeks A, Bulten J, Collée M, Groenendijk FH, Horlings HM, Jansen MPHM, Jonges TGN, Kooreman LFS, de Kroon CD, Lambrechts S, Lok CAR, Piek JM, Reyners AKL, Roes EM, Simons M, Wisman GBA, Yigit R, Zweemer RP, Mom CH, van de Vijver MJ, Dijk F; Archipelago of Ovarian Cancer Research Consortium. Zelisse HS, et al. Among authors: van gent mdjm. Gynecol Obstet Invest. 2022;87(6):389-397. doi: 10.1159/000528330. Epub 2022 Nov 30. Gynecol Obstet Invest. 2022. PMID: 36450222 Free article.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
Aronson SL, Lopez-Yurda M, Koole SN, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van Gent MDJM, Arts HJG, van Ham MAPC, van Dam PA, Vuylsteke P, Aalbers AGJ, Verwaal VJ, Van de Vijver KK, Aaronson NK, Sonke GS, van Driel WJ. Aronson SL, et al. Among authors: van gent mdjm. Lancet Oncol. 2023 Oct;24(10):1109-1118. doi: 10.1016/S1470-2045(23)00396-0. Epub 2023 Sep 11. Lancet Oncol. 2023. PMID: 37708912 Clinical Trial.
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma.
Hollis RL, Thomson JP, van Baal J, Ilenkovan N, Churchman M, van de Vijver K, Dijk F, Meynert AM, Bartos C, Rye T, Croy I, Diana P, van Gent M, Creedon H, Nirsimloo R, Lok C, Gourley C, Herrington CS. Hollis RL, et al. Sci Rep. 2023 May 11;13(1):7681. doi: 10.1038/s41598-023-34627-5. Sci Rep. 2023. PMID: 37169775 Free PMC article.
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome.
Thomson JP, Hollis RL, van Baal J, Ilenkovan N, Churchman M, van de Vijver K, Dijk F, Meynert AM, Bartos C, Rye T, Croy I, Diana P, van Gent M, Creedon H, Nirsimloo R, Nussey F, Lok C, Herrington CS, Gourley C. Thomson JP, et al. Gynecol Oncol. 2023 Jul;174:157-166. doi: 10.1016/j.ygyno.2023.04.011. Epub 2023 May 17. Gynecol Oncol. 2023. PMID: 37207500 Free article.
The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks.
Zelisse HS, de Ridder S, van Gent MDJM, Mom CH, Wisman GBA, Roes EM, Reyners AKL, Piek JM, Nieuwenhuyzen-de Boer GM, Lok CAR, de Kroon CD, Kooreman LFS, Janssen MJ, Jansen MP, Horlings HM, Collée M, Broeks A, Boere IA, Bart J, van Altena AM, Heeling M, Stoter IM, Voorham QJ, van de Vijver MJ, Dijk F, Belien JAM; Archipelago of Ovarian Cancer Research Consortium. Zelisse HS, et al. Among authors: van gent mdjm. Biopreserv Biobank. 2024 Apr 29. doi: 10.1089/bio.2023.0118. Online ahead of print. Biopreserv Biobank. 2024. PMID: 38682281
DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes.
Wever BMM, van den Helder R, van Splunter AP, van Gent MDJM, Kasius JC, Trum JW, Verhoeve HR, van Baal WM, Hulbert A, Verhoef L, Heideman DAM, Lissenberg-Witte BI, van Trommel NE, Steenbergen RDM, Bleeker MCG. Wever BMM, et al. Among authors: van gent mdjm. Int J Cancer. 2023 Jul 15;153(2):341-351. doi: 10.1002/ijc.34504. Epub 2023 Mar 23. Int J Cancer. 2023. PMID: 36912267
Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?
Lof P, van de Vrie R, Korse CM, van Gent MDJM, Mom CH, Rosier-van Dunné FMF, van Baal WM, Verhoeve HR, Hermsen BBJ, Verbruggen MB, Hemelaar M, van de Swaluw AMG, Knipscheer HC, Huirne JAF, Westenberg SM, van der Noort V, Amant F, van den Broek D, Lok CAR. Lof P, et al. Among authors: van gent mdjm. Gynecol Oncol. 2022 Aug;166(2):284-291. doi: 10.1016/j.ygyno.2022.05.025. Epub 2022 Jun 8. Gynecol Oncol. 2022. PMID: 35688656
Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.
Lof P, Retèl VP, Algera MD, van Gent MDJM, Gaarenstroom KN, van Driel WJ. Lof P, et al. Among authors: van gent mdjm. Gynecol Oncol. 2022 Jun;165(3):459-465. doi: 10.1016/j.ygyno.2022.03.028. Epub 2022 Apr 9. Gynecol Oncol. 2022. PMID: 35414427
20 results